Benefits of Using the CRISPR/Cas9 System for the Correction of Genetic Mutations

被引:0
|
作者
Sharipov, R. A. [1 ]
Omarov, M. A. [1 ]
Mulyukov, A. R. [1 ]
Dybova, A. I. [1 ]
Vyaseleva, E. T. [1 ]
Kayumova, N. B. [1 ]
Saitgalina, A. Sh. [1 ]
Ententeev, K. R. [1 ]
Iagafarov, I. R. [1 ]
Kuserbaev, I. V. [1 ]
Gubaeva, E. A. [1 ]
机构
[1] Bashkir State Med Univ, Ufa 450008, Russia
关键词
human diseases; CRISPR/Cas9; genome editing; therapy; drug development; CAS SYSTEMS; CRISPR-CAS9; MECHANISM; IMMUNITY;
D O I
10.3103/S0891416823030084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of the CRISPR/Cas9 gene scissors technology was a breakthrough in the development of gene therapy methods and attracted the attention of the entire scientific community. This technology provides prospects for the treatment of many neurodegenerative diseases and cancers that were previously considered almost incurable. To date, the mechanisms of the development and progression of these groups of nosologies are becoming increasingly studied due to discoveries in the field of molecular biology and genetics. However, the application of the CRISPR/Cas9 technology has some limitations and difficulties that should be considered. The development of works on the creation and selection of specific gene carriers, a thorough safety assessment of modern genetic manipulations, and the integrated participation of specialists from different fields of science will be important to solve the problems associated with the use of the CRISPR/Cas9 technology and achieve the desired therapeutic effect.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [1] Benefits of Using the CRISPR/Cas9 System for the Correction of Genetic Mutations
    R. A. Sharipov
    M. A. Omarov
    A. R. Mulyukov
    A. I. Dybova
    E. T. Vyaseleva
    N. B. Kayumova
    A. Sh. Saitgalina
    K. R. Ententeev
    I. R. Iagafarov
    I. V. Kuserbaev
    E. A. Gubaeva
    [J]. Molecular Genetics, Microbiology and Virology, 2023, 38 : 137 - 142
  • [2] Correction of Fanconi Anemia Mutation Using the Crispr/Cas9 System
    Kawashima, Nozomu
    Okuno, Yusuke
    Sekiya, Yuko
    Wang, Xinan
    Narita, Atsushi
    Doisaki, Sayoko
    Kamei, Michi
    Nishio, Nobuhiro
    Muramatsu, Hideki
    Hama, Asahito
    Takahashi, Yoshiyuki
    Kojima, Seiji
    [J]. BLOOD, 2015, 126 (23)
  • [3] Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System
    Kankan Wang
    Hongsheng Ouyang
    Zicong Xie
    Chaogang Yao
    Nannan Guo
    Mengjing Li
    Huping Jiao
    Daxin Pang
    [J]. Scientific Reports, 5
  • [4] Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System
    Wang, Kankan
    Ouyang, Hongsheng
    Xie, Zicong
    Yao, Chaogang
    Guo, Nannan
    Li, Mengjing
    Jiao, Huping
    Pang, Daxin
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [5] Correction: The application of CRISPR/Cas9 system in cervical carcinogenesis
    Chun Gao
    Ping Wu
    Lan Yu
    Liting Liu
    Hong Liu
    Xiangyu Tan
    Liming Wang
    Xiaoyuan Huang
    Hui Wang
    [J]. Cancer Gene Therapy, 2022, 29 : 625 - 626
  • [6] Using indCAPS to Detect CRISPR/Cas9 Induced Mutations
    Hodgens, Charles
    Nimchuk, Zachary L.
    Kieber, Joseph J.
    [J]. BIO-PROTOCOL, 2019, 9 (18):
  • [7] Genetic modification of the protozoan Eimeria tenella using the CRISPR/Cas9 system
    Tang, Xinming
    Suo, Jingxia
    Liang, Lin
    Duan, Chunhui
    Hu, Dandan
    Gu, Xiaolong
    Yu, Yonglan
    Liu, Xianyong
    Cui, Shangjin
    Suo, Xun
    [J]. VETERINARY RESEARCH, 2020, 51 (01)
  • [8] Genetic modification of the protozoan Eimeria tenella using the CRISPR/Cas9 system
    Xinming Tang
    Jingxia Suo
    Lin Liang
    Chunhui Duan
    Dandan Hu
    Xiaolong Gu
    Yonglan Yu
    Xianyong Liu
    Shangjin Cui
    Xun Suo
    [J]. Veterinary Research, 51
  • [9] High-throughput genetic screens using CRISPR–Cas9 system
    Jiyeon Kweon
    Yongsub Kim
    [J]. Archives of Pharmacal Research, 2018, 41 : 875 - 884
  • [10] Photoactivatable CRISPR/Cas9 System
    E. A. Akhmetova
    V. M. Golyshev
    I. P. Vokhtantcev
    M. I. Meschaninova
    A. G. Venyaminova
    D. S. Novopashina
    [J]. Russian Journal of Bioorganic Chemistry, 2021, 47 : 496 - 504